|
|||||
|
|
Real-world evidence of stroke prevention in patients with nonvalvular atrial fibrillation in the United States: the REVISIT-US study |
|
| Authors: | Craig I. Coleman Matthias Antz Kevin Bowrin Thomas Evers Edgar P. Simard Hendrik Bonnemeier |
| Affiliation: | 1. University of Connecticut School of Pharmacy, Storrs, CT, USA;2. craig.coleman@hhchealth.org;4. Hospital Oldenburg, Department of Cardiology, Oldenburg, Germany;5. Bayer Pharma AG, Berlin, Germany;6. Bayer Pharma AG, Wuppertal, Germany;7. Aetion Inc., New York, NY, USA;8. University Medical Center of Schleswig-Holstein, Department of Electrophysiology and Rhythmology, Kiel, Germany |
| Abstract: | |
| Keywords: | Anticoagulants Apixaban Nonvalvular atrial fibrillation Rivaroxaban Stroke prevention Warfarin |